100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Socra CCRP Exam Questions and Answers(SCORED A+) $10.19   Add to cart

Exam (elaborations)

Socra CCRP Exam Questions and Answers(SCORED A+)

 8 views  0 purchase
  • Course
  • Socra CCRP
  • Institution
  • Socra CCRP

When a short form is used for informed consent the witness must sign the short form or the summary? - ANSWER- False-they must sign both What is FDA form 3454 - ANSWER- Certification Financial Interests and Arrangements of Clinical Investigators What are the three main basic ethical principles...

[Show more]

Preview 2 out of 5  pages

  • March 1, 2024
  • 5
  • 2023/2024
  • Exam (elaborations)
  • Questions & answers
  • Socra CCRP
  • Socra CCRP
avatar-seller
IMORA
Socra CCRP Exam Questions and
Answers(SCORED A+)
Contract Research Organization - ANSWER- A person or an organization (commercial,
academic, or other) contracted by the sponsor to
perform one or more of a sponsor's trial-related duties and functions.

When a short form is used for informed consent the witness must sign the short form or
the summary? - ANSWER- False-they must sign both

What is FDA form 3454 - ANSWER- Certification Financial Interests and Arrangements
of Clinical Investigators

What are the three main basic ethical principles of the Belmont Report? - ANSWER-
Respect for persons.
Beneficence.
Justice.

Phase III - ANSWER- Study Participants: 300 to 3,000 volunteers who have the disease
or condition

Length of Study: 1 to 4 years

Purpose: Efficacy and monitoring of adverse reactions

Phase I - ANSWER- 20 to 100 healthy volunteers or people with the disease/condition.

Length of Study: Several months

Purpose: Safety and dosage

Phase II - ANSWER- Study Participants: Up to several hundred people with the
disease/condition.

Length of Study: Several months to 2 years

Purpose: Efficacy and side effects

The main concept of 21 CFR 50 is - ANSWER- protection of human subjects

21 CFR 50 part D - ANSWER- protection of childern

, A____________ can be any unfavorable and unintended sign) including an abnormal
laboratory finding), symptom, or disease temporally associated with the use of a
medicinal (investigational) product, whether or not related to the medicinal
(investigational) product. - ANSWER- adverse event

The FDA form 483 is used for _______ - ANSWER- Inspectional oberservation

The international ethical and scientific quality standard for designing, conducting,
recording and reporting trials that involve the participation of human subjects is known
as - ANSWER- GCP

A(n) _________ is an investigational or marketed product, or placebo, used as a
reference in a clinical trial. - ANSWER- comparator

What is 21 CFR 50.23 Subpart B? - ANSWER- the exception to the general
requirements

This form is used for the voluntary reporting of adverse events and product problems -
ANSWER- 3500

is permission to examine, analyze, verify, and reproduce any records and reports that
are important to evaluation of a clinical trial - ANSWER- direct access

21 cfr part b - ANSWER- ICF

Belmont Report (1979) - ANSWER- respect for persons, beneficence, justice

significant risk device - ANSWER- s a study of a device that presents a potential for
serious risk to the health, safety, or welfare of a subject and (1) is intended as an
implant; or (2) is used in supporting or sustaining human life; or (3) is of substantial
importance in diagnosing, curing, mitigating

A ________is a printed, optical or electronic document designed to record all of the
protocol required information to be reported to the sponsor on each trial subject -
ANSWER- crf

sae form - ANSWER- 3500a

The sponsor shall notify the FDA by telephone or fax any unexpected fatal or life-
threatening experience associated with the use of the drug as soon as possible but no
later than _____ after the sponsor's initial receipt of the information - ANSWER- 7 days

Unexpected serious suspected adverse reactions and observations from animal studies
suggesting significant risk to human subjects must be reported to FDA as soon as
possible but no later than within __ calendar days following the sponsor's initial receipt
of the information. - ANSWER- 15 days

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller IMORA. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $10.19. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

81531 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$10.19
  • (0)
  Add to cart